McGhan Medical Silicone-Filled Breast Implant Adjunct Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00581984
Recruitment Status : Completed
First Posted : December 28, 2007
Last Update Posted : October 16, 2013
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
This study will collect 5 year data about any possible health problems associated with breast implants. This data will be used to help see if the implants are both safe and effective. If they are proven safe and effective, they will continue to be available. If they are not proven safe and effective to the satisfaction of the FDA, they may not be available in the future.

Condition or disease
Breast Reconstruction With Silicone Implants

Detailed Description:

This prospective clinical study is being undertaken to document the safety of McGhan Medical Silicone-Filled Breast Implants. Patients will be evaluated pre-operatively, intraoperatively, and at one, three and five years following implant surgery. Safety of McGhan Medical Silicone-Filled Breast Implants will be assessed based on the incidence of medical complications, implant failure and serious adverse effects.

This prospective clinical study of McGhan Medical Silicone-Filled Breast Implants is part of an ongoing research effort to document the safety and effectiveness of silicone-filled breast implants.

Study Type : Observational
Actual Enrollment : 1016 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: McGhan Medical Silicone-Filled Breast Implant Adjunct Study
Study Start Date : September 1998
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Evidence of breast implant complications [ Time Frame: 10 years 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Females who are candidates for breast reconstructio

Inclusion Criteria:

  • Females of any age for which breast reconstruction is considered appropriate. (Patients under 18 years old require parental/legal guardian consent to participate).
  • Have any of the following conditions or situations present:

    • Post mastectomy surgical removal of the breast for cancer or other diseases;
    • Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity.(for any reason);
    • Severe ptosis requiring reconstruction (i.e. mastopexy);.
    • Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity. This does not include normal variants of asymmetry. Examples include, but are not limited to:Pectus excavatum, Pectus carinatum; Thoracic hypoplasia (Poland's syndrome, Scoliosis; Isolated rib deformities; Tuberous breasts; Congenital absence
    • Revision of implant procedure due to any of the following circumstances;
  • Previous augmentation or reconstruction with silicone- or saline-filled implants where problems exist, such as implant. rapture or significant capsular contracture (Baker Grade III or IV) requiring revision;

    • Contralateral mammaplasty in unaffected breast as a result of the affected breast requiring surgery (for one of the aforementioned circumstances), when medically indicated to provide symmetry.
  • Adequate tissue available to cover implants.
  • Saline-filled implants are not an appropriate choice.
  • Willingness to follow all study requirements, such as agreeing to all required follow-up visits, and acceptance of the risks involved as indicated by signing of the Patient Informed Consent document.

Exclusion Criteria:

  • Advanced fibrocystic disease considered to be premalignant-without accompanying subcutaneous mastectomy.
  • Existing carcinoma of the breast, without mastectomy.
  • Abscess or infection in the body at the time of enrollment.
  • Pregnant or nursing.
  • Have any disease, including uncontrolled diabetes; which is clinically known to impact wound healing ability.
  • Show tissue characteristics which are clinically incompatible with mammaplasty, such as tissue damage resulting from radiation, inadequate tissue, compromised vascularity or ulceration.
  • Have, or under treatment for, any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk.
  • Show psychological characteristics which, in the opinion of the surgeon, may be incompatible with the surgical procedure and the prosthesis, such as inappropriate attitude or motivation.
  • Wish to have augmentation mammaplasty, but do not have at least one of the diagnoses identified in Patient Inclusion Criteria item G #2, pages 7 & 8.
  • Are not willing to undergo further surgery for revision, if medically required.
  • Diagnosis of lupus or scleroderma.
  • Replacement of saline-filled implants solely for a less than desirable cosmetic outcome, such as wrinkling.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00581984

United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Principal Investigator: Peter Cordeiro, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center Identifier: NCT00581984     History of Changes
Other Study ID Numbers: 98-089
First Posted: December 28, 2007    Key Record Dates
Last Update Posted: October 16, 2013
Last Verified: October 2013

Keywords provided by Memorial Sloan Kettering Cancer Center:
breast cancer
breast reconstruction
silicone implants